Connect with us

News

Olivier Giroud Will Have A Medical With Ac Milan Before Signing A Two Year Contract According To Chelsea Transfer Reports

AC Milan’s Olivier Giroud is receiving a physical before signing a two-year contract with the Serie A club.

On Friday morning, around 7 a.m., the French striker arrived at Milan’s La Madonnina clinic to finalize his transfer from Chelsea.

Giroud’s transfer fee is expected to be about EUR1m (PS855,000), with an further EUR1m (PS855,000) in bonuses contingent on a certain number of appearances and Champions League qualifying.

Last summer, the 34-year-old signed a new one-year contract with Chelsea, and the club exercised an option to extend it for another 12 months in June.

4:41 With Olivier Giroud on the verge of joining AC Milan from Chelsea, we take a look back at some of his most memorable Premier League goals, including the scorpion kick!

In January 2018, Arsenal sold Giroud to Chelsea for PS18 million, six years after purchasing him for PS10.8 million from Ligue 1 champions Montpellier.

During his time at Stamford Bridge, he has scored 39 goals in 119 appearances, earning three major trophies, including the Champions League victory in May.

Giroud was part of France’s disastrous Euro 2020 campaign, which saw them eliminated on penalties by Switzerland in the round of 16 after a 3-3 extra-time draw.

AC Milan have already bought Fikayo Tomori from Chelsea, having exercised their PS25 million option to buy the teenage defender after a successful six-month loan term, and are also interested in Hakim Ziyech and Tiemoue Bakayoko.

Last season, the Italian team finished second in Serie A, ensuring their return to the Champions League after a seven-year hiatus.

Track the summer transfer window with Sky Sports You can keep up with all the latest transfer rumours and news in our dedicated Transfer Centre blog on Sky Sports’ digital platforms, as well as on Sky Sports News.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Must See

More in News